Skip to Main Content

Paper Details

The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58.
Diabetes Care
41
2021
Albuminuria, CVD, Dapagliflozin, SGLT2i, Sodium, Sodium-glucose cotransporter 2, albumin, atherosclerotic cardiovascular disease, cardiovascular death, cardiovascular or renal death, creatinine, dapagliflozin, diabetic kidney disease, end-stage kidney disease, glucose, participants, patients, type 2 diabetes
Author NameAffiliation
Jamie P DwyerVanderbilt University Medical Center
Deepak L BhattBrigham and Women's Hospital and Harvard Medical School
Marc S SabatineBrigham and Women's Hospital and Harvard Medical School
Marc S SabatineBrigham and Women's Hospital and Harvard Medical School
  • 1 - 4

Datasets

Release 1.2